ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients

Luo, Mengqi; Hou, Jia; Mai, Haoming; Chen, Jiaxuan; Chen, Haitao; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*南方医科大学; 中山大学
Alimentary Pharmacology and Therapeutics2022-9DOI: 10.1111/apt.17124
9被引6阅读
引用收藏
分享

摘要

Background Hepatitis B virus (HBV) infection is a serious global health burden. TRIM26 has been reported to affect hepatitis C virus replication. Aims To manifest the role of TRIM26 on HBV replication and explore if there are single-nucleotide polymorphisms (SNPs) in TRIM26 associated with response to pegylated interferon-alpha (PegIFN alpha) treatment in patients with chronic hepatitis B (CHB). Methods We investigated the effect and mechanism of TRIM26 on HBV replication in vitro. The association between SNPs in TRIM26 and PegIFN alpha treatment response was evaluated in two independent cohorts including 238 and 707 patients with HBeAg-positive CHB. Results Knockdown of TRIM26 increased, while overexpression of TRIM26 inhibited, HBV replication. Co-immunoprecipitation assays and immunofluorescence showed that TRIM26 interacted and co-localised with HBx. Co-transfection of HBx-HIS and TRIM26-FLAG plasmids in Huh7 cells showed that TRIM26 inhibited the expression of HBx. Furthermore, TRIM26 inhibited HBV replication by mediating HBx ubiquitination degradation, and TRIM26 SPRY domain was responsible for the interaction and degradation of HBx. Besides, IFN increased TRIM26 expression. TRIM26 rs116806878 was associated with response to PegIFN alpha in two CHB cohorts. Moreover, a polygenic score integrating TRIM26 rs116806878, STAT4 rs7574865 and CFB rs12614 (previously reported to be associated with response to PegIFN alpha) was related to response to PegIFN alpha in CHB. Conclusions TRIM26 inhibits HBV replication; IFN promotes TRIM26 expression. TRIM26 exerts an inhibitory effect on HBx by promoting ubiquitin-mediated degradation of HBx. Furthermore, TRIM26 rs116806878 is a potential predictive biomarker of response to PegIFN alpha in patients with CHB.

学科与关键词

关键词
X PROTEINEFFICACYTHERAPYBINDINGSMC5/6STAT4
相关
加载中…
  • TRIM26 INHIBITS HEPATITIS B VIRUS REPLICATION BY PROMOTING HBx DEGRADATION AND TRIM26 GENETIC POLYMORPHISM PREDICTS PEGIFNA TREATMENT RESPONSE OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Luo, Mengqi; Jiang, Deke
  • Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients
    Chen, Jiaxuan; Hou, Jia; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Clinical Pharmacology and Therapeutics, 2024, 115(2): 361-370.
  • An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients
    Hou, Jia; Dong, Chao; Chen, Jiaxuan; Chen, Haitao; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Antiviral Research, 2023, 220: 105741.
查看全部 →

发表信息

论文状态
公开发表
期刊
Alimentary Pharmacology and Therapeutics
发表日期
2022-09
卷期
第 56 卷, 第 5 期
页码
878-889
DOI
10.1111/apt.17124
语言
ENGLISH
成果收录
SCIE
资助标注
Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program, China [2017BT01S131]; Natural Science Foundation of Guangdong Province, China [2019A1515011423]; National Natural Science Foundation of China, China [81472618, 81670535]; National Science and Technology Major Project, China [2017ZX10202202, 2018ZX10301202]; Key-Areas Research and Development Program of Guangdong Province, China [2019B020227004]; Innovative Research Team Project of Guangxi Province, China [2017GXNSFGA198002]; Dean Fund of Nanfang Hospital, Southern Medical University, China [2018Z005]; Nanfang Hospital, China; Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University, China [2017J001]

作者

  • L

    Luo, Mengqi (第一作者)

    southern med univ · youjiang med univ nationalities

  • H

    Hou, Jia

    southern med univ

查看全部 8 位作者收起作者
  • M

    Mai, Haoming

    southern med univ

  • C

    Chen, Jiaxuan

    southern med univ

  • C

    Chen, Haitao

    southern med univ · sun yat sen univ

  • Z

    Zhou, Bin

    southern med univ

  • H

    Hou, Jinlin (通讯)

    southern med univ

  • J

    Jiang, De-Ke (通讯)

    southern med univ · youjiang med univ nationalities

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417